Clinical trial
Exploratory Clinical Study of Adult Pancreatic Progenitor-derived Islet Autologous Transplantation in the Treatment of Diabetes
NCT07118475 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Clinical Study of Adult Pancreatic Progenitor-derived Islet Autologous Transplantation in the Treatment of Diabetes
- Lead sponsor
- Shanghai Zhongshan Hospital
- Phase
- Phase 1
- Overall status
- Enrolling by invitation
- Start date
- October 7, 2025
- Completion date
- May 30, 2027
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.